PATRICK TOLAN: Open Payments
NPI 1962985416 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,257 in 210 payments from 21 companies in 2025. Trend: 2023 $2,312 · 2024 $3,737 · 2025 $4,257
Food & beverage: $4,148Education: $110
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $476 |
| ABBVIE INC. | 26 | $463 |
| Novartis Pharmaceuticals Corporation | 16 | $344 |
| Arcutis Biotherapeutics, Inc. | 22 | $332 |
| Regeneron Healthcare Solutions, Inc. | 7 | $324 |
| Botanix SB Inc | 11 | $286 |
| Amgen Inc. | 8 | $283 |
| GENZYME CORPORATION | 7 | $237 |
| PFIZER INC. | 16 | $186 |
| Lilly USA, LLC | 16 | $186 |
Products named: DUPIXENT, TREMFYA, Zoryve, SOFDRA, OTEZLA, SKYRIZI, CIBINQO, RINVOQ.
Industry payments across FL — which companies pay providers there.
